ORION CORPORATION ORION PHARMA ,   Finland

Glucocorticosteroid for topical application

Spray nasal dosed, 50 mcg / dose.

Glucocorticosteroid for topical application

Powder for inhalation dosed, 0.2 mg / dose.

Hypoglycemic agent for oral administration

Granules for oral administration, 2.5 g and 5 g.

Sedative remedy

Concentrate for solution for infusion, 100 μg / ml.

Anticoagulant of indirect action
Tablets 3 mg.
Rehydrating agent for oral administration.

Powder for solution for oral administration.

An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor + COMT inhibitor)
Tablets, film-coated 50 mg / 12.5 mg / 200 mg; _100 mg / 25 mg / 200 mg; 150 mg / 37.5 mg / 200 mg.
antitumor agent, alkylating compound

Capsules of 5 mg, 20 mg, 100 mg and 250 mg.

antitumor agent, alkylating compound.

Capsules of 140 mg and 180 mg.

blocker of "slow" calcium channels

Tablets, film-coated, 40 mg and 80 mg.

bronchodilator means - beta2-adrenomimetic selective.

Powder for inhalation dosed. 12 mcg - 120 doses.